Navigation Links
Merz, Inc. Announces Promotion of Katrina Church to Vice President, Chief Compliance Officer
Date:7/9/2012

GREENSBORO, N.C., July 9, 2012 /PRNewswire/ -- Merz, Inc. (US affiliate of Merz Pharma Group) today announced that Katrina Church has been promoted to vice president, chief compliance officer, effective July 1, 2012. Church will be responsible for providing strategic and operational leadership relating to compliance issues.

"Katrina brings extensive experience and a wealth of legal knowledge in pharmaceutical regulatory compliance to her new role," said Bill Humphries, president and chief executive officer of Merz, Inc. "Merz, Inc. is committed to a tight set of core values that foster a positive, productive and unified work environment. As a company, we do what is right even when it is not easy. Katrina plays a vital role in ensuring that we uphold the highest standards and values in this dynamic regulatory environment. We look forward to working with her on the many compliance requirements facing pharmaceutical companies today."

Church joined Merz in November 2009 and has more than 20 years of legal experience in various areas, including private legal practice and in-house corporate counsel positions. Prior to joining Merz, she was employed by Connetics, Inc. where she served as general counsel. Following the acquisition of Connetics by Stiefel Laboratories, Inc., in 2006, she provided legal consulting services to Stiefel.

Church graduated Magna Cum Laude from Duke University and obtained her Juris Doctor from the New York University School of Law. She is admitted to the Bar in California, certified in Healthcare Compliance and is a member of the American Corporate Counsel Association, American Health Lawyers Association, Health Care Compliance Association, and the Society of Corporate Compliance and Ethics. Church will remain at Merz, Inc. headquarters in Greensboro, N.C.

About Merz, Inc. Merz, Inc. develops and commercializes products for Merz Pharma Group. Areas of therapeutic focus include Neurology, Physiatry, Derma
'/>"/>

SOURCE Merz, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Akorn, Inc. Announces Second Quarter 2012 Earnings Release And Conference Call Information
2. ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS
3. Aoxing Pharmaceutical Company Announces Management Change
4. Oncos Therapeutics Announces Clinical Advisory Board for its Oncolytic Virus and Cancer Immunotherapy Development Programs
5. Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
6. ULURU Inc. Announces Completion Of $2.2mil Convertible Debt Offering
7. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
8. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
9. MicroVention Announces First Patient Enrollment In Clinical Trial To Compare Coiling Technologies For Treating Brain Aneurysms
10. Omron Healthcare Announces New Pedometers
11. Improved Maintenance and Control of Electronic Health Records. ICAP Patent Brokerage Announces for Auction Patented Techniques for Improved Patient Control and Selective Access to Electronic Medical Records
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... The issue: Mylan Pharmaceuticals ULC Canada, in consultation with Health ... 0.4 mg/metered dose due to the product missing the "dip ... A missing "dip tube" could pose a potential problem ... may lead patients to believe they are receiving the nitroglycerin, ... receiving nitroglycerin could place them at risk for either a ...
(Date:9/19/2014)... , Sept. 19, 2014 Medical science ... relationships with key opinion leaders (KOLs) who can ... Despite the critical nature of the MSL function, ... including altering the landscape for creating and maintaining ... to research, the oversight responsibility for the MSL ...
(Date:9/19/2014)... , Sept. 19, 2014 Harwood Feffer LLP ... board of directors of PDL BioPharma, Inc. ("PDL" or ... the board has breached its fiduciary duties to shareholders ... September 16, 2014, the Company disclosed: "On September 11, ... accounting firm, Ernst & Young LLP ("EY"), that it ...
Breaking Medicine Technology:Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2
... 2011 ,   EP ... of the Year Award at the European Mediscience,Awards, sponsored ... award, which honours clear and concise commentary in the,pharma ... research houses or specialist websites dedicated to,providing sharp, perceptive ...
... 24, 2011 New Phase 2 clinical trial data ... of Medicine show that patients with moderate to ... bardoxolone methyl for 52 weeks experienced a sustained improvement ... by estimated glomerular filtration rate (eGFR). The data were ...
Cached Medicine Technology:EP Vantage Wins Commentator of the Year Award at European Mediscience Awards 2011 2EP Vantage Wins Commentator of the Year Award at European Mediscience Awards 2011 3New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients With Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes 2New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients With Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes 3New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients With Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes 4
(Date:9/21/2014)... Colorado (PRWEB) September 21, 2014 High ... ten teams of disabled and able-bodied athletes rafted the ... completed a ropes course in pursuit of outdoor adventure. ... from national non-profit World T.E.A.M. Sports, disabilities proved to ... who successfully completed the three stage event. , Each ...
(Date:9/21/2014)... York, NY (PRWEB) September 21, 2014 ... http://www.thegranuflolawsuit.com/ ) have been added over the past ... claims that allege serious cardiovascular injuries caused by ... A Case List updated on September 15th shows ... in the U.S. District Court, District of Massachusetts. ...
(Date:9/21/2014)... An experienced review website in the global market, ... and announced that FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ), GoDaddy and ... There has been a boom in websites in recent ... increase in the number of web hosting companies that ... prices. VPS (Virtual Private Server) is the method of ...
(Date:9/21/2014)... 21, 2014 “Cluster headaches are sometimes ... and difficult to resolve,” said Steve Young of Ew ... of a pain that is more intense.” , “It ... cluster headaches, or migraines, that medical research is pointing ... system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) is a ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 Recently, BambooIndustry.com, ... a special offer for its bamboo panels ( http://www.bambooindustry.com/products/bamboo-panel/ ... the market; all of them are available at discounted ... , The company’s discounted bamboo panels are ... made of quality materials. Each of them is finely ...
Breaking Medicine News(10 mins):Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 2Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4Health News:Top10BestSEOHosting.com: FatCow, GoDaddy And Bluehost Are The Best VPS Hosting Suppliers 2Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Discounted Bamboo Panels For Sale At BambooIndustry.com 2
... with the non-profit organization HopeLab to deliver innovative interventions ... young people with chronic illnesses . Their first joint ... and young adults with cancer by offering free of ... works. It gives young people with cancer a sense ...
... are more active and have less body fat than ... today at the 54th American College of Sports Medicine ... associated with higher levels of self-reported leisure-time physical activity ... weight, status, and neighborhood, environment, walkability, and income between ...
... lawmakers to set aside 30 billion dollars over five years ... proposal fell short of funds needed to battle the global ... would visit Africa in June to assess HIV/AIDS-fighting strategies in ... works and what does not in battling the deadly disease. ...
... holy city of Najaf on Friday after receiving treatment for ... of the most powerful parties in the parliament, spent nearly ... in the United States and treatment in Iran. ... there for a long time, after he finished his initial ...
... study has found that people can be encouraged to walk ... if they are given the right kind of help. ... the Scottish Physical Activity Research Collaboration (SPARColl), the study suggests ... of waysface to face advice or telephone support, using pedometers, ...
... found three new drugs that may help transform the ... thus giving hope for chronically infected patients. ,The ... Hiroyu Hatano, and Steven Deeks at San Francisco General ... new drugs are the HIV integrase inhibitors, R5 inhibitors, ...
Cached Medicine News:Health News:CIGNA HealthCare Teams With HopeLab to Help Blast Teen Cancer 2Health News:Dog Owners More Active, Leaner 2Health News:Bush Seeks Doubling of AIDS-fighting Funds 2Health News:Top Iraqi Shiite Leader Returns Home 2
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
Stat Detection of Soluble Fibrin Monomer Complexes by the Hemagglutination Technique, 32 tests....
Batch Detection of Soluble Fibrin Monomer Complexes by the Hemagglutination Technique, 40 tests....
For use with catalog #0454....
Medicine Products: